Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura
This study has been completed.
Study NCT00005652   Information provided by Office of Rare Diseases (ORD)
First Received: May 2, 2000   Last Updated: September 8, 2008   History of Changes

No Study Results Posted for this Study
About Study Results Reporting
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)